F. Civeira

发表

The approach study: a randomized, double-blind, placebo-controlled, phase 3 study of volanesorsen administered subcutaneously to patients with familial chylomicronemia syndrome (FCS).

D. Gaudet, Joann D Flaim, L. Hemphill, 2017, Atherosclerosis.